The first list was identified as DE between epithelial and mesenchymal BC cell lines [23] (Supplementary Materials Table S2a), and the second list included DE RBPs upon the induction of the EMT process by the overexpression of the EMT activator ZEB1 in the H358 epithelial cells [27] (Supplementary Materials Table S2b). Here, ZEB1 is linked to breast cancer.